Glycogen synthase kinase 3 protein kinase activity is frequently elevated in human non-small cell lung carcinoma and supports tumour cell proliferation

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Vincent, Emma E ^a,b   Elder, Douglas J E ^a   O'Flaherty, Linda ^a   Pardo, Olivier E ^c   Dzien, Piotr ^a   Phillips, Lois ^d   Morgan, Carys ^a   Pawade, Joya ^d   May, Margaret T ^a   Sohail, Muhammad ^d   Hetzel, Martin R ^d   Seckl, Michael J ^c   Tavaré, Jeremy M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHIR 99021; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CENTRIFUGATION; CONTROLLED STUDY; DRUG POTENCY; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; LUNG ALVEOLUS CELL; NON SMALL CELL LUNG CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; TUMOR GROWTH; APOPTOSIS; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; ENZYMOLOGY; LUNG; LUNG TUMOR; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CELL PROLIFERATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG; LUNG NEOPLASMS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84915749469     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114725     Document Type: Article

References (48)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Sharma SV, Bell DW, Settleman J, Haber DA (2007) Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7: 169-181.
3. Cataldo VD, Gibbons DL, Perez-Soler R, Quintas-Cardama A (2011) Treatment of non-small-cell lung cancer with erlotinib or gefitinib. N Engl J Med 364: 947-955.
4. Pao W, Miller VA, Venkatraman E, Kris MG (2004) Predicting sensitivity of non-small-cell lung cancer to gefitinib: is there a role for P-Akt? J Natl Cancer Inst 96: 1117-1119.
5. Embi N, Rylatt DB, Cohen P (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 107: 519-527.
6. Woodgett JR (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. Embo J 9: 2431-2438.
7. Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR (2007) Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell 12: 957-971.
8. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789.
9. Frame S, Cohen P (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359: 1-16.
10. Proud CG (2007) Signalling to translation: how signal transduction pathways control the protein synthetic machinery. Biochem J 403: 217-234.
11. Doble BW, Woodgett JR (2003) GSK-3: tricks of the trade for a multi-tasking kinase. Journal of Cell Science 116: 1175-1186.
12. Jope RS, Yuskaitis CJ, Beurel E (2007) Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res 32: 577-595.
13. Mishra R (2010) Glycogen synthase kinase 3 beta: can it be a target for oral cancer. Mol Cancer 9: 144.
14. Kang T, Wei Y, Honaker Y, Yamaguchi H, Appella E, et al. (2008) GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell 13: 36-47.
15. Ban KC, Singh H, Krishnan R, Seow HF (2003) GSK-3beta phosphorylation and alteration of betacatenin in hepatocellular carcinoma. Cancer Lett 199: 201-208.
16. Zheng H, Saito H, Masuda S, Yang X, Takano Y (2007) Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas. Anticancer Res 27: 3561-3569.
17. Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD (2005) Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res 65: 2076-2081.
18. Cao Q, Lu X, Feng YJ (2006) Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells. Cell Res 16: 671-677.
19. Hilliard TS, Gaisina IN, Muehlbauer AG, Gaisin AM, Gallier F, et al. (2011) Glycogen synthase kinase 3beta inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growth. Anticancer Drugs 22: 978-985.
20. Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC, et al. (2008) Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature 455: 1205-1209.
21. Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, et al. (2008) Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res 68: 6643-6651.
22. Shakoori A, Ougolkov A, Yu ZW, Zhang B, Modarressi MH, et al. (2005) Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem Biophys Res Commun 334: 1365-1373.
23. Tang QL, Xie XB, Wang J, Chen Q, Han AJ, et al. (2012) Glycogen Synthase Kinase-3beta, NFkappaB Signaling, and Tumorigenesis of Human Osteosarcoma. J Natl Cancer Inst 104: 749-763.
24. Bilim V, Ougolkov A, Yuuki K, Naito S, Kawazoe H, et al. (2009) Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma. Br J Cancer 101: 2005-2014.
25. Zeng J, Liu D, Qiu Z, Huang Y, Chen B, et al. (2014) GSK3beta Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells. PLoS One 9: e91231.
26. Vincent EE, Elder DJ, Thomas EC, Phillips L, Morgan C, et al. (2011) Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer. Br J Cancer 104: 1755-1761.
27. Pardo OE, Arcaro A, Salerno G, Tetley TD, Valovka T, et al. (2001) Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells. Oncogene 20: 7658-7667.
28. Vincent EE, Elder DJ, Phillips L, Heesom KJ, Pawade J, et al. (2011) Overexpression of the TXNDC5 Protein in Non-small Cell Lung Carcinoma. Anticancer Res 31: 1577-1582.
29. Parker PJ, Caudwell FB, Cohen P (1983) Glycogen-Synthase from Rabbit Skeletal-Muscle - Effect of Insulin on the State of Phosphorylation of the 7 Phosphoserine Residues Invivo. European Journal of Biochemistry 130: 227-234.
30. Buss H, Dorrie A, Schmitz ML, Frank R, Livingstone M, et al. (2004) Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. J Biol Chem 279: 49571-49574.
31. Cole AR, Knebel A, Morrice NA, Robertson LA, Irving AJ, et al. (2004) GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons. J Biol Chem 279: 50176-50180.
32. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, et al. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem J 408: 297-315.
33. Finlay D, Patel S, Dickson LM, Shpiro N, Marquez R, et al. (2004) Glycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response element. BMC Mol Biol 5: 15.
34. Ma C, Wang J, Gao Y, Gao TW, Chen G, et al. (2007) The role of glycogen synthase kinase 3beta in the transformation of epidermal cells. Cancer Res 67: 7756-7764.
35. Ougolkov AV, Bone ND, Fernandez-Zapico ME, Kay NE, Billadeau DD (2007) Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells. Blood 110: 735-742.
36. Ding Q, He X, Xia W, Hsu JM, Chen CT, et al. (2007) Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer. Cancer Res 67: 4564-4571.
37. Woodgett JR (2012) Can a Two-Faced Kinase be Exploited for Osteosarcoma? J Natl Cancer Inst 104: 722-723.
38. Lim YW, Yoon SY, Choi JE, Kim SM, Lee HS, et al. (2010) Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model. Biochem Biophys Res Commun 395: 207-212.
39. Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436.
40. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, et al. (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406: 86-90.
41. Mamaghani S, Patel S, Hedley DW (2009) Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy. BMC Cancer 9: 132.
42. Ougolkov AV, Fernandez-Zapico ME, Bilim VN, Smyrk TC, Chari ST, et al. (2006) Aberrant nuclear accumulation of glycogen synthase kinase-3 beta in human pancreatic cancer: Association with kinase activity and tumor dedifferentiation. Clinical Cancer Research 12: 5074-5081.
43. Tao L, Fan F, Liu Y, Li W, Zhang L, et al. (2013) Concerted suppression of STAT3 and GSK3beta is involved in growth inhibition of non-small cell lung cancer by Xanthatin. PLoS One 8: e81945.
44. Li C, Zhang S, Lu Y, Zhang Y, Wang E, et al. (2013) The roles of Notch3 on the cell proliferation and apoptosis induced by CHIR99021 in NSCLC cell lines: a functional link between Wnt and Notch signaling pathways. PLoS One 8: e84659.
45. Shakoori A, Mai W, Miyashita K, Yasumoto K, Takahashi Y, et al. (2007) Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci 98: 1388-1393.
46. Al-Aynati MM, Radulovich N, Riddell RH, Tsao MS (2004) Epithelial-cadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia. Clin Cancer Res 10: 1235-1240.
47. Cho YJ, Yoon J, Ko YS, Kim SY, Cho SJ, et al. (2010) Glycogen synthase kinase-3beta does not correlate with the expression and activity of beta-catenin in gastric cancer. APMIS 118: 782-790.
48. Cohen Y, Chetrit A, Cohen Y, Sirota P, Modan B (1998) Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment. Med Oncol 15: 32-36.